Accrua is bringing biological age measurement into direct-to-consumer telehealth through a platform launching across all 50 U.S. states in October 2026. Developed by Deep Longevity, the service uses an AI-generated BloodAge report based on routine blood testing to compare a user’s biological and chronological age. Licensed clinicians can use this information to personalize care across areas including weight management, women’s health, men’s health, and peptide therapies. BloodAge is reassessed quarterly to track changes over time.
The platform extends Deep Longevity’s aging technology beyond its existing relationships with healthcare organizations and directly into the consumer market. Its largely subscription-based model creates potential for recurring revenue through ongoing testing, consultations, and treatment. By relying on established telehealth, physician, pharmacy, and compounding partners, Deep Longevity can offer nationwide access without building its own clinical infrastructure or maintaining drug inventory, supporting a more capital-efficient approach to U.S. expansion.
Image Credit: Deep Longevity
Key Themes Behind This Trend
- Biological Age Tracking
- AI-derived age biomarkers are turning routine bloodwork into longitudinal wellness metrics, opening space for personalized prevention platforms and recurring health optimization services.
- Subscription Telehealth Diagnostics
- Recurring testing and virtual consultations are reshaping telehealth from episodic care into continuous monitoring models with stronger consumer retention and data-driven personalization.
- AI-personalized Longevity Care
- Longevity algorithms connected to clinician-guided interventions create new possibilities for individualized therapies across weight, hormone, and metabolic health categories.
Where This Applies
- Telehealth
- Virtual care providers can differentiate through biomarker-based personalization that links diagnostics, consultations, prescriptions, and follow-up tracking in one consumer-facing experience.
- Preventive Healthcare
- The use of biological age reports supports a shift toward proactive risk management, where early lifestyle and treatment adjustments are informed by measurable aging indicators.
- Longevity Technology
- Consumer access to AI aging analytics expands the market beyond institutional healthcare partnerships, enabling scalable platforms built around repeat assessments and personalized health recommendations.
